Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis

PHASE3CompletedINTERVENTIONAL
Enrollment

10,000

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

November 26, 2017

Study Completion Date

November 26, 2017

Conditions
Tuberculosis
Interventions
DRUG

Vaccae

One vial of Vaccae diluted with 1.0ml sterile water for injection, take deep coxal muscle injection after shaking well, once every 2 weeks, 6 times totally.

DRUG

placebo

One vial of placebo diluted with 1.0ml sterile water for injection, take deep coxal muscle injection after shaking well,once every 2 weeks, 6 times totally.

Trial Locations (4)

545000

Liucheng County Diseases Control and Prevention, Liuzhou, Guangxi, Liuzhou

Liuzhou Center for Diseases Control and Prevention, Liuzhou, Guangxi, Liuzhou

Rongshui County Diseases Control and Prevention, Liuzhou, Guangxi, Liuzhou

547000

Jin Chengjiang Center for Diseases Control and Prevention, Hechi, Guangxi, Hechi

All Listed Sponsors
collaborator

Guangxi Center for Disease Control and Prevention

OTHER_GOV

collaborator

Liuzhou Center for Disease Control and Prevention,China

UNKNOWN

collaborator

Rongshui County Disease Control and Prevention,China

UNKNOWN

collaborator

Liucheng County Disease Control and Prevention,China

UNKNOWN

collaborator

Jin Chengjiang Center for Disease Control and Prevention,China

UNKNOWN

collaborator

National Institutes for Food and Drug Control, China

OTHER

collaborator

Air Force Military Medical University, China

OTHER

collaborator

Simoon Record Pharma Information Consulting Co., Ltd.

INDUSTRY

lead

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

INDUSTRY

NCT01979900 - Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis | Biotech Hunter | Biotech Hunter